Search Results - "Alimentary pharmacology & therapeutics"

Review article: gastrointestinal features in COVID‐19 and the possibility of faecal transmission by Tian, Yuan, Rong, Long, Nian, Weidong, He, Yan

“…Summary Background There is little published evidence on the gastrointestinal features of COVID‐19. Aims To report on the gastrointestinal manifestations and…”
Get full text

Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection by Zamani, M., Ebrahimtabar, F., Zamani, V., Miller, W. H., Alizadeh‐Navaei, R., Shokri‐Shirvani, J., Derakhshan, M. H.

“…Summary Background The epidemiology of Helicobacter pylori infection is poorly understood. Aim To establish the reported regional and national prevalence of H…”
Get full text

Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome by Ford, Alexander C., Harris, Lucinda A., Lacy, Brian E., Quigley, Eamonn M. M., Moayyedi, Paul

“…Summary Background Irritable bowel syndrome (IBS) is a chronic functional bowel disorder. Disturbances in the gastrointestinal microbiome may be involved in…”
Get full text

Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders by Gill, P. A., Zelm, M. C., Muir, J. G., Gibson, P. R.

“…Summary Background Butyrate, propionate and acetate are short chain fatty acids (SCFA), important for maintaining a healthy colon and are considered as…”
Get full text

Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection by Quraishi, M. N., Widlak, M., Bhala, N., Moore, D., Price, M., Sharma, N., Iqbal, T. H.

“…Summary Background Clostridium difficile infection (CDI) is the commonest nosocomial cause of diarrhoea. Faecal microbiota transplantation (FMT) is an approved…”
Get full text

Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19 by Kulkarni, Anand V., Kumar, Pramod, Tevethia, Harsh Vardhan, Premkumar, Madhumita, Arab, Juan Pablo, Candia, Roberto, Talukdar, Rupjyoti, Sharma, Mithun, Qi, Xiaolong, Rao, Padaki Nagaraja, Reddy, Duvvuru Nageshwar

“…Summary Background The incidence of elevated liver chemistries and the presence of pre‐existing chronic liver disease (CLD) have been variably reported in…”
Get full text

Systematic review with meta‐analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome by Zamani, Mohammad, Alizadeh‐Tabari, Shaghayegh, Zamani, Vahid

“…Summary Background Irritable bowel syndrome (IBS) is a common and potential disabling functional gastrointestinal disorder. Studies have revealed a possible…”
Get full text

Review article: the global emergence of Helicobacter pylori antibiotic resistance by Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., Valasek, M. A.

“…Summary Background Helicobacter pylori is one of the most prevalent global pathogens and can lead to gastrointestinal disease including peptic ulcers, gastric…”
Get full text

Editorial: low population mortality from COVID‐19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity by Rhodes, Jonathan M., Subramanian, Sreedhar, Laird, Eamon, Kenny, Rose A.

“…LINKED CONTENT This article is linked to Al‐Ani et al and Garg et al papers. To view these articles, visit https://doi.org/10.1111/apt.15779 and…”
Get full text

Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world by Henry, Linda, Paik, James, Younossi, Zobair M.

“…Summary Background The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing in parallel with obesity and type 2 diabetes. Aim To review the…”
Get full text

Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease by Nakajima, Atsushi, Eguchi, Yuichiro, Yoneda, Masato, Imajo, Kento, Tamaki, Nobuharu, Suganami, Hideki, Nojima, Toshiaki, Tanigawa, Ryohei, Iizuka, Masakazu, Iida, Yuki, Loomba, Rohit

“…Summary Background Pemafibrate is a novel, selective peroxisome proliferator‐activated receptor α modulator (SPPARMα). In mice, Pemafibrate improved the…”
Get full text

Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases by Stine, Jonathan G., Wentworth, Brian J., Zimmet, Alex, Rinella, Mary E., Loomba, Rohit, Caldwell, Stephen H., Argo, Curtis K.

“…Summary Background Given the lack of long‐term prospective studies, it is challenging for clinicians to make informed decisions about screening and treatment…”
Get full text

Systematic review: the global incidence of faecal microbiota transplantation‐related adverse events from 2000 to 2020 by Marcella, Cicilia, Cui, Bota, Kelly, Colleen R., Ianiro, Gianluca, Cammarota, Giovanni, Zhang, Faming

“…Summary Background Faecal microbiota transplantation (FMT) is an effective treatment in C. difficile infection (CDI) and is currently being investigated in…”
Get full text

Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies by Navarro, Pilar, Arias, Ángel, Arias‐González, Laura, Laserna‐Mendieta, Emilio J., Ruiz‐Ponce, Miriam, Lucendo, Alfredo J.

“…Summary Background The frequency of eosinophilic oesophagitis (EoE) occurrence is escalating. Current diagnostic criteria recently proposed for the disease,…”
Get full text

Systematic review: exercise‐induced gastrointestinal syndrome—implications for health and intestinal disease by Costa, R. J. S., Snipe, R. M. J., Kitic, C. M., Gibson, P. R.

“…Summary Background “Exercise‐induced gastrointestinal syndrome” refers to disturbances of gastrointestinal integrity and function that are common features of…”
Get full text

Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases by Mitrev, N., Vande Casteele, N., Seow, C. H., Andrews, J. M., Connor, S. J., Moore, G. T., Barclay, M., Begun, J., Bryant, R., Chan, W., Corte, C., Ghaly, S., Lemberg, D. A., Kariyawasam, V., Lewindon, P., Martin, J., Mountifield, R., Radford‐Smith, G., Slobodian, P., Sparrow, M., Toong, C., Langenberg, D., Ward, M. G., Leong, R. W.

“…Summary Background Therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD) patients receiving anti‐tumour necrosis factor (TNF) agents can help…”
Get full text

2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases by Taxonera, Carlos, Sagastagoitia, Iñigo, Alba, Cristina, Mañas, Norberto, Olivares, David, Rey, Enrique

“…Summary Background Data on patients with inflammatory bowel diseases (IBD) who have had 2019 novel coronavirus (SARS‐CoV‐2) disease (COVID‐19) are needed. Aims…”
Get full text

Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging by Flint, Anne, Andersen, Grit, Hockings, Paul, Johansson, Lars, Morsing, Anni, Sundby Palle, Mads, Vogl, Thomas, Loomba, Rohit, Plum‐Mörschel, Leona

“…Summary Background Glucagon‐like peptide‐1 receptor agonists may be a treatment option in patients with non‐alcoholic fatty liver disease (NAFLD). Aims To…”
Get full text

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection by Cammarota, G., Masucci, L., Ianiro, G., Bibbò, S., Dinoi, G., Costamagna, G., Sanguinetti, M., Gasbarrini, A.

“…Summary Background Faecal microbiota transplantation (FMT) from healthy donors is considered an effective treatment against recurrent Clostridium difficile…”
Get full text

Systematic review with meta‐analysis: the efficacy of probiotics in inflammatory bowel disease by Derwa, Y., Gracie, D. J., Hamlin, P. J., Ford, A. C.

“…Summary Background Ulcerative colitis (UC) and Crohn's disease (CD) are inflammatory bowel diseases (IBD). Evidence implicates disturbances of the…”
Get full text